Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Pathologic Complete Response × eltrombopag × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Classical hematology 1

Conditions

Thrombocytopenia 3 Leukemia, Myeloid, Acute 2 Pathologic Complete Response 1 Leukemia, Myelomonocytic, Chronic 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Leukemia 1 Jacobs syndrome 1

Interventions

eltrombopag 1 durvalumab 1 Pemetrexed 1 Paclitaxel 1 Gemcitabine 1 Cytarabine 1 Cisplatin 1 Carboplatin 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01656252 2020-11-03

PrE0901

PrECOG, LLC.

Phase 1/2 Terminated

15 enrolled 5 charts

Classical hematologyOther hematologic neoplasm

Jacobs syndrome, Pathologic Complete Response, Leukemia, Thrombocytopenia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡